RXRX
Recursion Pharmaceuticals Inc
3.90$
+5.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +58.4% | +113.2% | +39.9% | +107.6% | +49.6% | +129.4% | |
| – | +209.9% | +245.8% | +88.0% | +91.7% | +52.7% | +36.2% | |
| – | +393.1% | +189.4% | +98.7% | – | – | – | |
| – | +7,457.4% | -101.0% | – | -142.2% | – | – | |
| – | +72.3% | +490.9% | -6.1% | -68.0% | +14.6% | -52.8% | |
| – | +123.5% | +3,009.2% | – | -105.3% | – | -106.5% | |
| – | – | – | – | – | – | – | |
| – | +796.9% | -302.4% | -99.3% | +751.1% | +479.6% | +89.8% | |
| – | +104.4% | +86.3% | -66.3% | -9.2% | +117.0% | +71.5% | |
| – | +222.9% | -85.3% | +835.9% | -159.8% | – | -25.1% | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.